Analyst Price Target is $180.08
▲ +14.99% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for AmerisourceBergen in the last 3 months. The average price target is $180.08, with a high forecast of $201.00 and a low forecast of $169.00. The average price target represents a 14.99% upside from the last price of $156.61.
Current Consensus is
Buy
The current consensus among 13 polled investment analysts is to buy stock in AmerisourceBergen. This Buy consensus rating has held steady for over two years.
AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Read More